BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Prach AT, Malek M, Tavakoli M, Hopwood D, Senior BW, Murray FE. H 2 -antagonist maintenance therapy versus Helicobacter pylori eradication in patients with chronic duodenal ulcer disease: a prospective study: DUODENAL ULCER TREATMENT STRATEGIES. Alimentary Pharmacology & Therapeutics 1998;12:873-80. [DOI: 10.1046/j.1365-2036.1998.00391.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Louw J, Marks I. The treatment of peptic ulcer disease: . Current Opinion in Gastroenterology 1999;15:497. [DOI: 10.1097/00001574-199911000-00007] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
2 Puig I, Baylina M, Sánchez-delgado J, López-gongora S, Suarez D, García-iglesias P, Muñoz N, Gisbert JP, Dacoll C, Cohen H, Calvet X. Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole for Helicobacter pylori first-line treatment. J Antimicrob Chemother 2016;71:2740-53. [DOI: 10.1093/jac/dkw220] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
3 Janknegt R, Engels LG. Formulary Management of Eradication Therapies for Helicobacter pylori: Drug Selection by Means of the SOJA Method. Disease Management and Health Outcomes 2000;7:251-66. [DOI: 10.2165/00115677-200007050-00003] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
4 Hobsley M, Tovey FI, Holton J. Precise role of H pylori in duodenal ulceration. World J Gastroenterol 2006; 12(40): 6413-6419 [PMID: 17072972 DOI: 10.3748/wjg.v12.i40.6413] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
5 Ford AC, Gurusamy KS, Delaney B, Forman D, Moayyedi P. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people. Cochrane Database Syst Rev 2016;4:CD003840. [PMID: 27092708 DOI: 10.1002/14651858.CD003840.pub5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
6 Ford AC, Delaney BC, Forman D, Moayyedi P. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database Syst Rev. 2006;CD003840. [PMID: 16625592 DOI: 10.1002/14651858.cd003840.pub4] [Cited by in Crossref: 53] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
7 Hobsley M, Tovey FI, Holton J. Controversies in the Helicobacter pylori/duodenal ulcer story. Trans R Soc Trop Med Hyg. 2008;102:1171-1175. [PMID: 18589464 DOI: 10.1016/j.trstmh.2008.04.035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
8 Ford A, Delaney B, Forman D, Moayyedi P. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database Syst Rev. 2004;4:CD003840. [PMID: 15495066 DOI: 10.1002/14651858.cd003840.pub2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
9 Nyssen OP, Pérez-Aisa Á, Tepes B, Rodrigo-Sáez L, Romero PM, Lucendo A, Castro-Fernández M, Phull P, Barrio J, Bujanda L, Ortuño J, Areia M, Brglez Jurecic N, Huguet JM, Alcaide N, Voynovan I, María Botargues Bote J, Modolell I, Pérez Lasala J, Ariño I, Jonaitis L, Dominguez-Cajal M, Buzas G, Lerang F, Perona M, Bordin D, Axon T, Gasbarrini A, Marcos Pinto R, Niv Y, Kupcinskas L, Tonkic A, Leja M, Rokkas T, Boyanova L, Shvets O, Venerito M, Bytzer P, Goldis A, Simsek I, Lamy V, Przytulski K, Kunovský L, Capelle L, Milosavljevic T, Caldas M, Garre A, Mégraud F, O'Morain C, Gisbert JP; Hp-EuReg Investigators. Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg). Helicobacter 2020;25:e12686. [PMID: 32173974 DOI: 10.1111/hel.12686] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
10 Gené E, Calvet X, Azagra R. Diagnosis of Helicobacter pylori after triple therapy in uncomplicated duodenal ulcers--a cost-effectiveness analysis. Aliment Pharmacol Ther 2000;14:433-42. [PMID: 10759623 DOI: 10.1046/j.1365-2036.2000.00735.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
11 Dutta AK, Phull PS. Treatment of Helicobacter pylori infection in the presence of penicillin allergy. World J Gastroenterol 2021; 27(44): 7661-7668 [PMID: 34908805 DOI: 10.3748/wjg.v27.i44.7661] [Reference Citation Analysis]